ライフサイエンスコーパス: complete blood count

1 (PI); 4) gingival index (GI); 5) CRP; and 6) complete blood count.

2 city was quantified via body weight loss and complete blood count.

3 d hematoanalyzer and reported as part of the complete blood count.

4 poietic reconstitution was assessed by doing complete blood counts.

5 can be identified in individuals with normal complete blood counts.

6 coagulation studies, serum chemistries, and complete blood counts.

7 t times from 4-23 days post-treatment, and a complete blood count along with blood chemistry analyses

8 Complete blood count analysis demonstrated that disrupti

9 of 48 routinely obtained blood specimens for complete blood count analysis in our institutional labor

10 y obtained from 48 hospitalized patients for complete blood count analysis.

11 the cardiac surgical intensive care unit for complete blood count analysis.

12 Her complete blood count and basic metabolic profile were un

13 g a new allopurinol prescription, and QI 3 = complete blood count and creatine kinase check every 6 m

14 Laboratory test results, including complete blood count and electrolyte, creatinine, creati

15 Complete blood counts and comparison of means and the pr

16 Complete blood counts and flow cytometric analyses were

17 visits and during outpatient care, including complete blood counts and hepatic and renal function tes

18 els, hepatitis C virus (HCV) RNA levels, and complete blood counts and underwent liver biopsy at the

19 to a hospital laboratory for an urinalysis, complete blood count, and a standard blood chemistry pan

20 cal parameters, including fever, heart rate, complete blood count, and bacteremia; and evaluated the

21 othrombin time, partial thromboplastin time, complete blood count, and bleeding time were recorded.

22 ell, F/F cell, gamma-globin synthesis ratio, complete blood count, and chemistry were measured.

23 Subjects had undergone a phlebotomy, a complete blood count, and cognitive and dietary assessme

24 anoma progression with physical examination, complete blood count, and liver function tests every 3 m

25 ttery of medical tests (electrocardiography, complete blood count, and measurement of serum levels of

26 f the pulmonary circulation, pulse oximetry, complete blood count, and serum chemistries and pulmonar

27 teine (tHcy), and creatinine concentrations, complete blood count, and vitamin supplementation in 550

28 rum and pulmonary cytokines, lung histology, complete blood counts, and intestinal proliferation were

29 concentrations of ISATX247 and cyclosporine, complete blood counts, and serum chemistry profiles were

30 DNA level, HBsAg level, liver function test, complete blood count, aspartate aminotransferase-to-plat

31 howed no evidence of changes in body weight, complete blood count, blood chemistry profile, cardiac c

32 ry evaluations for infection (urine culture, complete blood count, blood culture, and wound culture)

33 Further work-up consisted of a complete blood count, bone marrow biopsy, and immunohist

34 rmountain Risk Score (IMRS), composed of the complete blood count (CBC) and basic metabolic profile (

35 Several parameters of preoperative complete blood count (CBC) and inflammation-associated b

36 The complete blood count (CBC) provides a high-level assessm

37 ocyte/monocyte-colony-forming unit (CFU-GM), complete blood count (CBC), and donor chimerism at vario

38 n saturation, comprehensive blood chemistry, complete blood count (CBC), and urinalysis.

39 Blood analyses included a complete blood count (CBC), sequential multiple analyzer

40 Complete blood count (CBC), serum chemistries, bile acid

41 participants received anemia education and a complete blood count (CBC).

42 Clinical observations and complete blood counts (CBC) were performed.

43 ria were physician-ordered blood culture and complete blood count [CBC]), and 102 controls (healthy b

44 Complete blood counts (CBCs) were obtained on the day of

45 Body weights, complete blood counts (CBCs), and blood pressure were ob

46 The use of complete blood counts, chemistry panels, bone scans, che

47 a standard battery of 18 biochemical tests, complete blood counts, disease complications, duration o

48 monary artery catheter insertions; number of complete blood counts, electrolytes, and cultures sent f

49 valuation regardless of the type of uveitis (complete blood count, erythrocyte sedimentation rate, C-

50 overy of BM stem and progenitor cells and of complete blood counts following irradiation.

51 The patient underwent serial measurements of complete blood count, hepatic profile, coagulation profi

52 s in the immunized macaques, as indicated by complete blood counts, leukocyte differentials and hepat

53 Complete blood counts, liver and renal function test res

54 that age-specific likelihood values for the complete blood count may determine risk of infection.

55 rn, number of patients with various abnormal complete blood count measurements, and location-specific

56 rs are adaptively identified using recurrent complete blood count measurements, which sufficiently co

57 nts identified as having coexistent disease, complete blood counts, multiphasic biochemical testing,

58 analyzed in patients with available baseline complete blood counts (n=3717).

59 For the complete blood count, no significant differences were ob

60 labeling efficiency, in vitro stability, or complete blood count of leukocytes labeled with stabiliz

61 Complete blood counts of all three of our patients revea

62 ts of Star:Star-mPEG/antimiR-145 with serial complete blood counts of leukocytes and serum metabolic

63 IFN-alpha, liver and kidney function tests, complete blood counts, or pathology of major organs are

64 We included people 30 years or older with complete blood counts performed in usual clinical care a

65 5,231 individuals in the cohort, 154,179 had complete blood counts performed under acute conditions a

66 Complete blood counts, plasma interleukin-6 (IL-6) level

67 es not affect hematopoiesis as determined by complete blood count profiles.

68 Complete blood counts, renal and liver function assessme

69 A basic serum chemistry test and complete blood count revealed no abnormal findings.

70 Analysis of complete blood counts revealed a median hemoglobin level

71 Recipients were followed up with daily complete blood count, scheduled chest radiographs, and b

72 Blood samples were analyzed for complete blood count, serum chemistry profile, level of

73 nical examination, routine laboratory tests (complete blood count, serum creatinine level), urine alb

74 included: a) the tests to be obtained daily: complete blood count, serum electrolytes, urea nitrogen,

75 whole-mouth clinical periodontal parameters, complete blood count, smoking status, and age.

76 They are monitored clinically by complete blood counts, specifically with measurements of

77 ied by para-phenylenediamine staining, and a complete blood count system was used to measure the numb

78 th negligible/negative (< 1%) yield included complete blood counts (therapy-related leukemia), dipsti

79 ecent rejection episode, cyclosporine level, complete blood count, time between transplantation and o

80 ated with BTNPs showed better restoration of complete blood count to normal level, and significantly

81 Complete blood counts to measure total eosinophils, frac

82 24 children with SCA with a neurologic exam, complete blood count, transcranial Doppler ultrasound (T

83 ical history and laboratory tests, including complete blood count, transferrin saturation, and other

84 ed at 1 and 3 h after preparation, whereas a complete blood count was obtained at 3 h after preparati

85 Blood chemistries, complete blood count, weight, liver, and kidney biopsies

86 ferritin level, routine chemistry panel, and complete blood count were determined.

87 The comprehensive metabolic panel and complete blood count were normal throughout and after th

88 Complete blood counts were available for four patients,

89 TPO plus G-CSF or vehicle and complete blood counts were measured.

90 Complete blood counts were monitored for 60 days postirr

91 Complete blood counts were monitored for 60 days postirr

92 Liver chemistries and complete blood counts were monitored, and patients were

93 Complete blood counts were normal or near normal in all

94 no history of underlying malignancy, and the complete blood counts were normal.

95 stem cell transplantation, peripheral blood complete blood counts were performed and examined for po

96 Complete blood counts were performed every 2 years.

97 sment of renal function, liver function, and complete blood count, were within normal limits.

98 taken at baseline and at study completion; a complete blood count with differential and comprehensive

99 Complete blood count with differential, serology screen

100 hematology analyzer during performance of a complete blood count with differential.